Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 217
Filter
Add more filters

Complementary Medicines
Publication year range
1.
J Med Food ; 27(5): 449-459, 2024 May.
Article in English | MEDLINE | ID: mdl-38421731

ABSTRACT

Although hair loss contributes to various social and economic, research methods for material development are currently limited. In this study, we established a research model for developing materials for hair growth through the regulation of ß-catenin. We confirmed that 100 nM tegatrabetan (TG), a ß-catenin inhibitor, decreased the proliferation of human hair follicle dermal papilla cells (HFDPCs) at 72 h. In addition, TG-induced apoptosis suppressed the phosphorylation of GSK-3ß and Akt, translocation of ß-catenin from the cytosol to the nucleus, and the expression of cyclin D1. Interestingly, TG significantly increased the G2/M arrest in HFDPCs. Subcutaneous injection of TG suppressed hair growth and the number of hair follicles in C57BL/6 mice. Moreover, TG inhibited the expression of cyclin D1, ß-catenin, keratin 14, and Ki67. These results suggest that TG-induced inhibition of hair growth can be a promising model for developing new materials for enhancing ß-catenin-mediated hair growth.


Subject(s)
Cell Proliferation , Cyclin D1 , Glycogen Synthase Kinase 3 beta , Hair Follicle , Hair , Mice, Inbred C57BL , Signal Transduction , beta Catenin , beta Catenin/metabolism , Animals , Humans , Hair Follicle/growth & development , Hair Follicle/metabolism , Hair Follicle/drug effects , Mice , Signal Transduction/drug effects , Cell Proliferation/drug effects , Hair/growth & development , Hair/drug effects , Hair/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Cyclin D1/metabolism , Cyclin D1/genetics , Apoptosis/drug effects , Male , Proto-Oncogene Proteins c-akt/metabolism , Phosphorylation
2.
J Cosmet Dermatol ; 23(5): 1638-1644, 2024 May.
Article in English | MEDLINE | ID: mdl-38247260

ABSTRACT

BACKGROUND: Characterized by progressive hair loss due to an excessive response to androgens, androgenetic alopecia (AGA) affects up to 50% of males and females. Minoxidil is one of approved medications for AGA but inadequate responses occur in many patients. AIMS: To determine whether 1565 nm non-ablative fractional laser (NAFL) could yield better therapeutic benefits for patients with AGA as compared with 5% minoxidil. METHODS: Thirty patients with AGA were enrolled; they were randomly assigned into the laser or minoxidil treatment groups. For the laser treatment group, patients were treated by 1565 nm NAFL at 10 mJ, 250 spots/cm2 with 2 weeks intervals for 4 sessions in total. For the minoxidil treatment group, 1-milliliter of topical 5% minoxidil solution was applied to hair loss area twice a day. RESULTS: The primary outcomes were the changes in numerous hair growth indexes at the Week 10 as compared with the baselines. Both 1565 nm NAFL and 5% minoxidil led to significantly greater hair densities and diameters in patients at the Week 10 than the baselines (p < 0.01). As compared with 5% minoxidil, 1565 nm NAFL showed significantly greater improvements in total hair number, total hair density (hair/cm2), terminal hair number, terminal hair density (hair/cm2), number of hair follicle units, and average hair number/number of hair follicle units. CONCLUSIONS: Our data demonstrate that 1565 nm NAFL exhibits superior clinical efficacy in some aspects of hair growth to the topical minoxidil. It is a safe and effective modality in treating AGA.


Subject(s)
Alopecia , Minoxidil , Adult , Female , Humans , Male , Middle Aged , Young Adult , Alopecia/drug therapy , Alopecia/therapy , Hair/growth & development , Hair/drug effects , Lasers, Solid-State/therapeutic use , Low-Level Light Therapy/instrumentation , Low-Level Light Therapy/methods , Minoxidil/administration & dosage , Single-Blind Method , Treatment Outcome , Vasodilator Agents/administration & dosage
3.
J Cosmet Dermatol ; 22(4): 1286-1296, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36762396

ABSTRACT

INTRODUCTION: Alopecia areata (AA) is a challenging disease with variable treatment outcomes. Hair follicles express vitamin D receptors. Therefore, vitamin D3 may be promising for AA treatment through immunomodulatory mechanisms. The efficacy of bimatoprost in scalp AA treatment was reported by few studies. OBJECTIVE: To evaluate the efficacy and safety of microneedling (MN) with topical vitamin D3 versus MN with bimatoprost in comparison with MN alone in the treatment of localized AA. PATIENTS AND METHODS: Seventy-five patients with localized AA were divided into three groups. The first group: 25 patients were treated with MN alone. The second group: 25 patients treated with MN combined with topical vitamin D3. The third group: 25 patients treated with MN combined with bimatoprost solution. The response was evaluated clinically and dermoscopically. RESULTS: At the end of the study, all groups showed a statistically significant decrease in the SALT score compared to the baseline. The clinical response (regrowth scale): vitamin D and bimatoprost groups showed a statistically significant higher regrowth scale compared to MN alone group (p-value = 0.000). After treatment, hair regrowth was significantly higher in MN combined with bimatoprost than in MN combined with topical vitamin D3. However, after 3 months of follow-up, there was no statistically significant difference between both groups. Side effects were mild and transient in all groups. CONCLUSION: Topical vitamin D3 and bimatoprost combined with MN are safe and effective therapeutic options for localized AA.


Subject(s)
Alopecia Areata , Bimatoprost , Cholecalciferol , Dermatologic Agents , Dry Needling , Humans , Alopecia Areata/drug therapy , Alopecia Areata/therapy , Bimatoprost/administration & dosage , Bimatoprost/adverse effects , Cholecalciferol/administration & dosage , Cholecalciferol/adverse effects , Hair/drug effects , Hair/growth & development , Treatment Outcome , Dry Needling/methods , Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Combined Modality Therapy , Administration, Topical
4.
Carbohydr Polym ; 278: 118811, 2022 Feb 15.
Article in English | MEDLINE | ID: mdl-34973721

ABSTRACT

The aim of this study was to optimize the separation and purification technology of water-soluble Ginkgo biloba leaves polysaccharides (WGBP), analyze its composition characteristics, observe its hair-growth promoting effect in alopecia areata mice, clarify the polysaccharide fraction with bioactive activities, and explore its anti-inflammation mechanism. We isolated acidic polysaccharides (WGBP-A2) and purified a RG-I type polysaccharide (WGBP-A2b) with a molecular weight of 44 kDa. Results showed that WGBP-A2 could significantly increase the contents of VEGF and HGF in the skin tissue of alopecia areata mice, decrease the contents of Inflammatory factors in the serum. On a cellular level, the expressions of p-p65 and p-IκBα, TNF-α and IL-1ß in HUVECs treated with WGBP-A2b were down-regulated. The bioinformatic analysis showed that the inflammation signaling pathway was significantly changed. Its specific mechanism may be related to its regulating the expression of p-p65 p-IκBα, TNF-α and IL-1ß proteins in the inflammation signaling pathway.


Subject(s)
Ginkgo biloba/chemistry , Hair/drug effects , Plant Extracts/pharmacology , Polysaccharides/pharmacology , Animals , Hair/growth & development , Mice , Mice, Inbred C57BL , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Polysaccharides/chemistry , Polysaccharides/isolation & purification
5.
Clin Exp Dermatol ; 47(3): 534-541, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34618367

ABSTRACT

BACKGROUND: The oil of the grass Cyperus rotundus (purple nutsedge) is an effective and safe treatment option for a variety of conditions. It has anti-inflammatory and antipigmenting properties. There have been no clinical trials comparing topical C. rotundus oil with skin-lightening treatments for axillary hyperpigmentation. AIM: To assess the efficacy of C. rotundus essential oil (CREO) in treating axillary hyperpigmentation, and compare with another active treatment hydroquinone (HQ) and a placebo (cold cream) in this study. METHODS: The study included 153 participants, who were assigned to one of three study groups: CREO, HQ group or placebo group. A tri-stimulus colorimeter was used to assess pigmentation and erythema. Two independent experts completed the Physician Global Assessment, and the patients completed a self-assessment questionnaire. RESULTS: CREO had significantly (P < 0.001) better depigmenting effects than HQ. CREO and HQ did not differ significantly in terms of depigmentation effects (P > 0.05); however, there were statistically significant differences in anti-inflammatory effects and decrease in hair growth (P < 0.05) in favour of CREO. CONCLUSIONS: CREO is a cost-effective and safe treatment for axillary hyperpigmentation.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Axilla , Cyperus , Dermatologic Agents/therapeutic use , Hyperpigmentation/drug therapy , Oils, Volatile/therapeutic use , Administration, Topical , Adult , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/economics , Axilla/pathology , Colorimetry , Cost-Benefit Analysis , Dermatologic Agents/adverse effects , Dermatologic Agents/economics , Double-Blind Method , Female , Hair/drug effects , Hair/growth & development , Humans , Hydroquinones/therapeutic use , Hyperpigmentation/pathology , Oils, Volatile/adverse effects , Oils, Volatile/economics , Skin Cream , Young Adult
6.
Molecules ; 26(4)2021 Feb 05.
Article in English | MEDLINE | ID: mdl-33562583

ABSTRACT

The aim of this work was to optimize our natural hair dyeing system which we described in our previous work and to compare with other dyeing systems. Therefore, we investigated concentration limits of matcha and mordant and compared this new dyeing method with commercial permanent systems on the market. Completely unpigmented hair tresses were dyed with matcha powder (camelia sinensis) and iron(II)-lactate. To investigate the wash fastness and concentration limits, the differently dyed hair tresses were spectrophotometrically measured. The comparison of the damage potential for which cysteic acid is an indicator was measured by NIR. The concentration of matcha and mordant are responsible for the intensity of the color results. The higher the matcha or the mordant concentration, the darker the color results of the dyed hair tresses. Hair damage of matcha mordant dyeing is comparable with results of commercial permanent hair coloration systems. Moreover, the results of wash fastness of matcha mordant dyed hair tresses is comparable and even better by tendency to permanent colored hair tresses.


Subject(s)
Camellia sinensis/chemistry , Hair/drug effects , Iron/chemistry , Lactic Acid/chemistry , Lactic Acid/pharmacology , Tannins/pharmacology , Color , Humans
7.
J Drugs Dermatol ; 20(1): 55-61, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33400421

ABSTRACT

Hair loss is a complex and multi-factorial problem that is associated with significant psychological morbidity in women. Menopausal women represent a significant percentage of those affected, since the menopausal hormonal transition can be a contributing factor. A novel nutraceutical supplement has been specifically formulated with phytoactives to improve hair growth and quality in menopausal women (Nutrafol® Women’s Balance Capsules). The objective of this 6-month, randomized, double-blind, placebo-controlled study was to assess the safety and efficacy of this oral supplement to promote hair growth in perimenopausal, menopausal, and postmenopausal women with self-perceived thinning. Subjects were randomized to the study supplement (n=40) or placebo (n=30). The primary endpoint was a statistically significant increase in the number of terminal and vellus hairs based on phototrichogram analysis. Daily intake of the nutraceutical supplement resulted in progressive and significant increase in terminal and total hair counts on days 90 (P<0.01) and 180 (P<0.01) compared to placebo. The vellus hair counts significantly increased for the active treatment group (P<0.05) by day 180 while significantly decreasing for the placebo group subjects. Hair shedding progressively and significantly decreased for the active group compared to placebo, culminating in a reduction of 32.41% by day 180 (P<0.01). The study supplement was well-tolerated. ClinicalTrials.gov Identifier: NCT04048031 J Drugs Dermatol. 2021;20(1):55-61. doi:10.36849/JDD.5701 THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE. PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN. NO PURCHASE NECESSARY. PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.


Subject(s)
Alopecia/drug therapy , Dietary Supplements/adverse effects , Hair/drug effects , Menopause/physiology , Phytochemicals/administration & dosage , Administration, Oral , Adult , Aged , Alopecia/diagnosis , Alopecia/physiopathology , Dermoscopy/methods , Double-Blind Method , Female , Hair/diagnostic imaging , Hair/growth & development , Humans , Middle Aged , Photography , Phytochemicals/adverse effects , Placebos/administration & dosage , Surveys and Questionnaires , Treatment Outcome
8.
Phytomedicine ; 81: 153423, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33310308

ABSTRACT

BACKGROUND: As a traditional and typical prescription of prominently activating blood circulation to remove blood stasis, Xuefu Zhuyu decoction (XZD) consists of 15 kinds of herbal medicine. Clinical investigations have showed that XZD could significantly promote the new hair generation of alopecia areata (AA) patients characterized by Qi stagnation and blood stasis. PURPOSE: The purpose of this study was executed to determine whether the mechanisms by which XZD stimulated newborn hair were related to its anti-inflammatory effects. METHODS: Clinical AA individuals were recruited to confirm the efficies of XZD. High performance liquid chromatography (HPLC) analysis was performed to qualitatively and quantitatively determine the contents of 15 compounds in XZD. Schrodinger molecular docking and in vivo surface plasmon resonance (SPR) techniques were used to evaluate the potential binding properties of compounds to target proteins. C3H/HeJ mice were randomly assigned to groups control, AA, and the XZD administration (6.5, 13.0 and 26.0 g/kg/d). Except for mice in control group, all the mice in the other groups were treated with a 21-day chronic unpredictable mild stress (CUMS) induced AA. Hematoxylin-eosin (H&E) staining was performed to determine the degree of pathological damage to the skin. Enzyme-linked immunosorbent assay (ELISA) was performed to detect levels of interleukin-6 (IL-6), interleukin-1 beta (IL-1ß) and tumor necrosis factor alpha (TNF-α) and in serum and skin tissues. Western blot, immunohistochemistry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were used to examine the expression levels of IL-6, IL-1ß, TNF-α and osteopontin proteins and genes in skin tissues. RESULTS: XZD could visibly promote hair regeneration of AA patients. The potential active ingredients in XZD prescription included at least amygdalin, hydroxysafflor yellow A, kaempferide, ferulic acid, catalpol, verbascoside, ß-ecdysone, platycodin D, paeoniflorin, naringin, neohesperidin, liquiritin, glycyrrhizic acid, saikosaponin A and saikosaponin D. The results of molecular docking and SPR analysis showed that verbascoside, liquiritin, kaempferide and amygdalin showed the best potential binding properties with IL-6, IL-1ß, TNF-α and osteopontin, respectively. Pathological evaluation showed that compared with the CUMS group, the administration of XZD significantly promoted hair regeneration, evidenced by increased number of skin hair follicles in C3H/HeJ AA mice. Compared with control group, ELISA data showed that the levels of IL-6, IL-1ß and TNF-α in serum and skin tissues of CUMS induced AA mice were significantly increased, while XZD administration dramatically restrained the contents of the three pro-inflammatory factors. Western blot, immunohistochemistry, and qRT-PCR results further demonstrated that XZD administration notably down-regulated the protein and gene expression levels of osteopontin, IL-6, IL-1ß and TNF-α in comparation with CUMS group. CONCLUSION: XZD could dramatically ameliorate CUMS-induced AA damage in the skin of C3H/HeJ mice, possibly by suppressing the levels of IL-6, IL-1ß, TNF-α and osteopontin.


Subject(s)
Alopecia Areata/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Hair/drug effects , Alopecia Areata/etiology , Alopecia Areata/pathology , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Cytokines/chemistry , Cytokines/metabolism , Female , Hair/growth & development , Hair Follicle/drug effects , Humans , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Male , Mice, Inbred C3H , Molecular Docking Simulation , Regeneration/drug effects , Skin/drug effects , Skin/metabolism , Skin/pathology , Surface Plasmon Resonance , Tumor Necrosis Factor-alpha/metabolism , Young Adult
9.
Int J Cosmet Sci ; 43(2): 136-143, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33043463

ABSTRACT

OBJECTIVE: Cosmetic and dermatological products, mainly the hair treatments, are projected to have remarkable growing in coming years. Nanotechnology, specifically nanoemulsions, has potential to be used in several hair products, owing to their beneficial properties. Concurrently, plant-derived cosmetics have become more popular over the years to consumers who prefer a safer, natural and sustainable approach. There is a lack of studies combining plant oils and nanotechnology for haircare formulations. In this work, different plant oil-loaded nanoemulsions were prepared to investigate the influence of their particle size, zeta potential and composition on hair treatment efficacy. METHODS: Coconut, olive and Abyssinian oils, alone or in combination, were loaded into nanoemulsions by high-pressure homogenization method (HPH). The mean particle size, polydispersity index and zeta potential were measured by the dynamic light scattering (DLS) method, and a stability test was performed for five months. A sensorial screening evaluation performed by the analyst and the combing test using Dia-Stron® instrumentation were applied on hair tresses treated by these nanoemulsions. RESULTS: The use of different plant oils for nanoemulsion resulted in distinct final particle sizes and zeta potential. However, results suggested no significant difference between them in hair tresses combing efficacy compared by Dia-Stron® instrument testing. Moreover, the plant-loaded nanoemulsions with increased concentration of cationic surfactant indicated a 50% reduction in combing force using this device when compared to control, in addition to better sensory results by screening test compared to other nanoemulsions and control. CONCLUSION: The composition of plant oils, particle size or zeta potential of the prepared nanoemulsions does not seem to significantly influence hair performance. Thus, we suggest that finding the right balance between cationic surfactant and plant oils may be the most appropriate path to develop effective nanoemulsions in hair treatment.


OBJECTIF: Les produits cosmétiques et dermatologiques, principalement les traitements capillaires, devraient connaître une croissance remarquable dans les années à venir. La nanotechnologie, en particulier les nanoémulsions, a le potentiel d'être utilisée dans plusieurs produits capillaires, en raison de leurs propriétés bénéfiques. Parallèlement, les cosmétiques d'origine végétale sont devenus plus populaires au fil des ans auprès des consommateurs qui préfèrent une approche plus sûre, naturelle et durable. Il existe un manque d'études combinant les huiles végétales et la nanotechnologie pour les formulations de traitement capillaire. Dans ce travail, différentes nanoémulsions contenant de l'huile végétale ont été préparées pour étudier l'influence de leur taille de particule, de leur potentiel zêta et de leur composition sur l'efficacité du traitement capillaire. MÉTHODES: Les huiles de noix de coco, d'olive et d'Abyssinie, seules ou en combinaison, ont été chargées dans des nanoémulsions par méthode d'homogénéisation à haute pression (HPH). La taille moyenne des particules, l'indice de polydispersité et le potentiel zêta ont été mesurés par la méthode de diffusion dynamique de la lumière (DLS), et un test de stabilité a été effectué pendant cinq mois. Une évaluation sensoriel réalisée par l'analyste et le test de peignage à l'aide de l'instrumentation Dia - Stron® ont été appliqués sur les cheveux traités par ces nanoémulsions. RÉSULTATS: L'utilisation de différentes huiles végétales pour la nanoémulsion a donné des tailles de particules finales et un potentiel zêta distinct. Cependant, les résultats n'ont suggéré aucune différence significative entre eux dans l'efficacité du peignage des cheveux par rapport aux tests d'instruments Dia-Stron®. De plus, la nanoémulsion chargée avec une concentration plus élevée de tensioactif cationique a indiqué une réduction de 50% de la force de peignage en utilisant ce dispositif par rapport au contrôle, et, le screening a montré de meilleurs résultats sensoriels par rapport aux autres nanoémulsions et contrôle. CONCLUSION: La composition des huiles végétales, la taille des particules ou le potentiel zêta des nanoémulsions préparées ne semblent pas influencer significativement les performances capillaires. Ainsi, nous suggérons que trouver le bon équilibre entre un tensioactif cationique et des huiles végétales peut être la voie la plus appropriée pour développer des nanoémulsions efficaces dans le traitement des cheveux.


Subject(s)
Emulsions , Hair/drug effects , Nanostructures , Plant Oils/pharmacology , Humans
10.
Molecules ; 25(16)2020 Aug 13.
Article in English | MEDLINE | ID: mdl-32823713

ABSTRACT

This current study investigates the facilitative effects and mechanisms of decursin, a major component of Angelica gigas Nakai (AGN), and AGN root extract on hair growth in mice. We perform high-performance liquid chromatography on AGN extract to show it contains 7.3% decursin. Hairs in mouse dorsal skin are shaved distilled in water, 0.15% decursin, and 2% AGN root extract (0.15% decursin in the diluted extract) and topically applied twice a day for 17 days. Hematoxylin and eosin staining are done to examine the morphological changes in the hair follicles. To compare the effects of decursin and AGN extract on inflammatory cytokines in the dorsal skin, Western blot analysis and immunohistochemistry for tumor necrosis factor α (TNF-α) and interleukin (IL)-1ß as pro-inflammatory cytokines, and IL-4 and IL-13 as anti-inflammatory cytokines are conducted. The results show that the application of decursin and AGN extract confer effects on hair growth. Hair growth is significantly facilitated from seven days after the treatments compared to that in the control group, and completely grown hair was found 17 days after the treatments. The protein levels and immunoreactivity of TNF-α and IL-1ß in this case are significantly decreased, whereas the IL-4 and IL-13 levels and immunoreactivity are significantly increased compared to those in the control group. Additionally, high-mobility group box 1, an inflammatory mediator, is elevated by the topical application of decursin and AGN extract. Taken together, the treatment of mouse dorsal skin with AGE root extract containing decursin promotes hair growth by regulating pro- and/or anti-inflammatory cytokines. We, therefore, suggest that AGN root extract as well as decursin can be utilized as materials for developing hair growth-facilitating treatments.


Subject(s)
Angelica/chemistry , Benzopyrans/pharmacology , Butyrates/pharmacology , Cytokines/metabolism , Hair/drug effects , Plant Extracts/pharmacology , Plant Roots/chemistry , Skin/drug effects , Animals , Apoptosis/drug effects , HMGB1 Protein/metabolism , Hair/growth & development , Inflammation/metabolism , Male , Mice , Mice, Inbred C57BL , Skin/cytology , Skin/metabolism
11.
Dermatol Surg ; 46(12): 1698-1704, 2020 12.
Article in English | MEDLINE | ID: mdl-32769526

ABSTRACT

BACKGROUND: The conditioned media from adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) contains cytokines and growth factors that stimulate hair regeneration. OBJECTIVE: We evaluated the efficacy and safety of human ADSC-CM treatment on patients who underwent nonablative fractional laser for the treatment of androgenetic alopecia (AGA). MATERIALS AND METHODS: Thirty patients who underwent nonablative fractional laser treatment were topically administered either ADSC-CM or placebo solution. As a primary outcome, phototrichograms were taken to measure changes in hair density at each visit. In addition, global improvement scores (GISs) were compared by clinical digital photographs, which were taken at the initial and final visits, and assessed by 2 independent dermatologists. Finally, the investigator's improvement score was measured by questionnaire response during the final visit. RESULTS: Hair density comparisons during the treatment period revealed that the ADSC-CM group had significantly higher final densities compared with the placebo group. The GIS of the ADSC-CM group was also significantly higher than the placebo group. Finally, no adverse effects associated with the application of ADSC-CM were noted during the study. CONCLUSION: The application of ADSC-CM after nonablative fractional laser treatment accelerated increases in hair density and volume in AGA patients.


Subject(s)
Alopecia/therapy , Culture Media, Conditioned/pharmacology , Hair/drug effects , Low-Level Light Therapy/methods , Mesenchymal Stem Cells/metabolism , Adipose Tissue/cytology , Administration, Topical , Adult , Alopecia/diagnosis , Combined Modality Therapy/adverse effects , Combined Modality Therapy/methods , Double-Blind Method , Female , Hair/growth & development , Humans , Low-Level Light Therapy/adverse effects , Male , Middle Aged , Photography , Placebos/administration & dosage , Placebos/adverse effects , Treatment Outcome , Young Adult
12.
Pharm Biol ; 58(1): 400-409, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32420784

ABSTRACT

Context: Although Salvia plebeia (SP) R. Brown (Labiatae) is known to possess various biological activities, the effects of SP on hair growth have not been elucidated.Objective: To investigate the hair growth potential of SP extract by using human dermal papilla cells (hDPCs) and C57BL/6 mice.Materials and methods: The entire SP plant sample was ground into powder and extracted with 99.9% methyl alcohol. Various concentrations of SP extract were added to hDPCs to evaluate the proliferation, migration, and factors related to hair growth and cycling. Effect of topical SP administration on hair regrowth was tested in vivo in male C57BL/6 mice for 21 days.Results: SP extract significantly increased the proliferation of cultured hDPCs at doses of 15.6 and 31.3 µg/mL compared to control group by 123% and 132%, respectively. Expression of hepatocyte growth factor increased while the level of TGF-ß1 and SMAD2/3 decreased when treated with SP extract. At the molecular level, the extract activated Wnt/ß-catenin signalling by raising ß-catenin and phospho-GSK3ß expression. SP extract also exerted anti-apoptotic and proliferative effects in hDPCs by increasing the Bcl-2/Bax ratio and activating cell proliferation-related proteins, ERK and Akt. Finally, the extract caused an induction of the anagen phase leading to significantly enhanced hair growth in treated male mice.Discussion and conclusion: Our results indicate that SP extract has the capacity to activate hDPCs into a proliferative state to promote hair growth. Further research is necessary to determine the bioactive components and their mechanisms of action responsible for SP-related hair growth effect.


Subject(s)
Hair Follicle/drug effects , Hair Follicle/growth & development , Plant Extracts/pharmacology , Salvia , Animals , Cell Proliferation/drug effects , Cell Proliferation/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Hair/cytology , Hair/drug effects , Hair/growth & development , Hair Follicle/cytology , Humans , Male , Mice , Mice, Inbred C57BL , Plant Extracts/isolation & purification
13.
J Ethnopharmacol ; 258: 112831, 2020 Aug 10.
Article in English | MEDLINE | ID: mdl-32283192

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Prunus mira Koehne (P. mira, Tibetan name: ཁམབུ།) is a kind of medicinal plant commonly used in Tibetan areas. The classic Tibetan medicine book Jingzhu Materia Medica records that "the nut oil from P. mira is used to cure loss of hair, eyebrows, beards, etc." but the clinical experience has not been explored. Hair loss (alopecia) is a skin disease that becomes a common concern in Chinese society since it affects the appearance of a person. This paper studies the effectiveness of nut oil from P. mira in promoting hair growth and its working mechanism. MATERIALS AND METHODS: The content of different components in the nut oil from P. mira was determined by HPLC. Two hair removal methods (sodium sulfide and hair removal cream) were used to study the effect of different doses on hair growth in KM mice. Then select the effective group, and use C57BL/6 mice to determine the number of hair follicles, dermal thickness, ß-catenin, GSK3ß and Wnt10 b mRNA and protein expression. RESULTS: The contents of α-tocopherol, ß-sitosterol, Vitamin E, Oleic acid and linoleic acid in nut oil from P. mira growing in 12 different regions were determined by HPLC. The linearity reached 0.999. The RSD of precision, stability, repeatability, and sample recovery was less than 3%. The dose-effect relationship suggested that 30.13 and 14.07 mg medicinal material·(cm2·d)-1 oil promoted hair growth and the dose effect was positively correlated. 30.13 mg medicinal material·(cm2·d)-1 nut oil from P. mira can accelerate hair follicles into the anagen, increasing Wnt 10 b mRNA expression, ß-catenin mRNA and protein expression, and GSK-3 ß protein expression. CONCLUSION: This study improved the quality control of nut oil from P. mira and found that it has the effect of promoting hair growth in mice. The working mechanism may be related to Wnt/ß-catenin signaling pathway.


Subject(s)
Hair Follicle/drug effects , Hair/drug effects , Plant Oils/pharmacology , Prunus/chemistry , Alopecia/drug therapy , Animals , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Female , Glycogen Synthase Kinase 3 beta/genetics , Hair/growth & development , Hair Follicle/metabolism , Male , Mice , Mice, Inbred C57BL , Plant Oils/chemistry , Plant Oils/isolation & purification , Rabbits , Wnt Signaling Pathway/drug effects
14.
Expert Opin Pharmacother ; 21(5): 603-612, 2020 04.
Article in English | MEDLINE | ID: mdl-32066284

ABSTRACT

Introduction: Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. It is characterized by androgen related progressive thinning of hair in a defined pattern. It results in diminished self-esteem, reduced confidence and distress in affected men, irrespective of age or stage of baldness. An effective treatment for hair baldness is needed.Areas covered: In androgenetic alopecia, hair follicles undergo progressive miniaturization. Genetic factors and androgens are key role-players in disease pathogenesis. Herein the authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha reductase inhibitors, minoxidil and prostaglandins. Non-pharmacologic approaches are also explored.Expert opinion: Androgenetic alopecia progresses over time and although the current available medical treatments like finasteride and minoxidil are effective in arresting the progression of the disease, they allow only partial regrowth of hair at its best. Early treatment achieves a more optimal outcome. Non-pharmacologic treatments like PRP can be considered in patients refractory to medical treatment.Abbreviations: MPHL: male pattern hair loss; AGA: androgenetic alopecia; DHT: dihydrotestosterone; 5AR: 5-alpha-reductase; VEGF: vascular endothelial growth factor; PG's: prostaglandins (PG's); PGD2R: prostaglandin D2 receptor; VPA: valproic aid; SR: Serenoa Repens; PRP: platelet-rich plasma; PDGF: platelet derived growth factor; TGF: transforming growth factor; ERK: extracellular signal-regulated kinase; PKB: protein kinase B; LLLT: low-level laser therapy; ROS: reactive oxygen species; RCT: randomized control trial; SFRP1: secreted frizzled related protein 1; DP: dermal papilla; PDE5: phosphodiesterase 5.


Subject(s)
Alopecia/drug therapy , Finasteride/therapeutic use , Minoxidil/therapeutic use , Prostaglandins/therapeutic use , Administration, Oral , Administration, Topical , Alopecia/radiotherapy , Dry Needling , Finasteride/administration & dosage , Hair/drug effects , Hair/growth & development , Humans , Low-Level Light Therapy , Male , Minoxidil/administration & dosage , Prostaglandins/administration & dosage , Randomized Controlled Trials as Topic , Treatment Outcome
15.
J Cosmet Dermatol ; 19(6): 1463-1472, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31904175

ABSTRACT

BACKGROUND: Many over the counter and consumer packaged goods are promoted to enhance the appearance of hair, skin, and nails for the consumer. Nutrition is a major factor in affecting the health and appearance of hair, skin, and nails. In addition to how one eats, dietary supplementation may play a role in overall health and in the physical appearance. AIMS: It was the aim of this study to objectively and subjectively evaluate the impacts of a nutritional intervention as compared to placebo on the appearances of hair, skin, and nails in healthy middle-aged adults. METHODS: Randomized, double-blind placebo-controlled study with 88 subjects randomized evenly to Study Product (BiovaBio™ 450 mg/d, n = 44) or Placebo (n = 44) for 12-weeks. Outcome tests included TrichoScan HD (hair), Canfield Visia® -CR (skin), modified FACE-Q (skin), and anchored Likert Scales (nails). RESULTS: Oral hydrolyzed eggshell membrane ingestion was associated with a significant improvement in facial skin appearance in crow's feet in 4 weeks and skin tone in 8 weeks, with significant impact on hair thickness, reduction in hair breakage and improvement in hair growth at 4, 8, and 12 weeks. There were no observed subjective improvements for nails (appearance, strength or growth). CONCLUSIONS: Oral supplementation of 450 mg/d hydrolyzed eggshell membrane for 12 weeks is associated with improvement in the appearance of facial skin and hair.


Subject(s)
Biological Products/administration & dosage , Dietary Supplements/adverse effects , Egg Shell/chemistry , Hair/drug effects , Skin/drug effects , Administration, Oral , Adult , Aged , Animals , Biological Products/adverse effects , Cohort Studies , Double-Blind Method , Face , Female , Hair/growth & development , Humans , Male , Middle Aged , Nails/drug effects , Nails/growth & development , Placebos/administration & dosage , Placebos/adverse effects , Skin Aging/drug effects , Skin Pigmentation/drug effects , Treatment Outcome
16.
Phytother Res ; 34(2): 428-431, 2020 Feb.
Article in German | MEDLINE | ID: mdl-31680356

ABSTRACT

Hair loss affects millions of people worldwide, but currently available treatment options are often dissatisfying due to side effects or limited efficacy. Pea sprout extract has been shown to improve hair density when applied topically, but its mode of action and effectiveness upon oral administration remain unknown. Our study has now shown that the application of a fluid containing 2% pea sprout extract on a defined scalp zone of 10 volunteers enhances the expression of defined genes relevant for hair, namely fibroblast growth factor-7 (FGF7) and noggin, by 56 and 85%, respectively. Additionally, a subsequent pilot nutrition intervention study in 21 volunteers proved that pea sprout extract is also effective when consumed as dietary supplement. The daily intake of 100 mg pea sprout extract (AnaGain™ Nu) for 8 weeks significantly reduced hair loss already after 28 days of treatment (p < 0.002). No adverse events were reported. Consequently, pea sprout extract may be an effective means to safely promote hair growth and reduce hair loss in individuals experiencing excessive hair shedding.


Subject(s)
Alopecia/drug therapy , Dietary Supplements , Pisum sativum/chemistry , Plant Extracts/therapeutic use , Administration, Cutaneous , Administration, Oral , Adult , Carrier Proteins/genetics , Female , Fibroblast Growth Factor 7/genetics , Gene Expression Regulation , Hair/drug effects , Hair/growth & development , Humans , Male , Middle Aged , Pilot Projects , Seedlings/chemistry , Young Adult
17.
Support Care Cancer ; 28(4): 1829-1837, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31338640

ABSTRACT

PURPOSE: This study aimed to evaluate the impact of a topical lotion (CG428) on hair thickness and density in breast cancer survivors with permanent chemotherapy-induced alopecia (PCIA). METHODS: The study was a double-blind, randomized controlled trial which conducted from February 2016 to December 2016 at the Samsung Comprehensive Cancer Center in Seoul, South Korea. Breast cancer patients with PCIA were randomized on average of 3.5 years after chemotherapy. Topical lotion (Batch DT023) is a botanical drug under development containing a novel patented blend of 4 botanical ingredients: citrus, cocoa, guarana, and onion. Participants were asked to self-apply the study product or placebo twice per day for 6 months. Changes in hair density and thickness were assessed using a noninvasive bioengineering device, and patient-reported outcomes were evaluated at 3 and 6 months after randomization. RESULTS: A total of 35 patients were randomized to intervention (N = 18) or placebo (N = 17). Patients in the intervention group were older than those in the placebo group (52.1 vs. 41.6 years; P < 0.001). The mean hair density (SD) at baseline was 97.6 (6.4) and 126.8 (30.3) hairs/cm2 in the intervention and placebo group, respectively (P = 0.005). The corresponding values for hair thickness were 49.9 (12.7) and 48.1 (8.4) µm, respectively. After 6 months, hair density had increased by 34.7 and 24.9% compared with baseline in the intervention and control groups, respectively (P = 0.37). Corresponding values for hair thickness were 19.8 and 35.6%, respectively (P = 0.23). Similar findings were observed after age adjustment. DISCUSSION: In this pilot randomized clinical trial, we observed safety, tolerability, and a trend toward the efficacy of CG428 vs. placebo, especially regarding hair density and self-reported improvement.


Subject(s)
Alopecia/chemically induced , Alopecia/drug therapy , Antineoplastic Agents/adverse effects , Breast Neoplasms , Cancer Survivors , Plant Extracts/administration & dosage , Plant Preparations/administration & dosage , Administration, Topical , Adult , Breast Neoplasms/drug therapy , Breast Neoplasms/rehabilitation , Cacao/chemistry , Citrus/chemistry , Double-Blind Method , Female , Hair/drug effects , Hair/growth & development , Humans , Middle Aged , Onions/chemistry , Paullinia/chemistry , Pilot Projects , Plant Extracts/adverse effects , Plant Preparations/adverse effects , Republic of Korea
18.
Pharmacol Res ; 152: 104599, 2020 02.
Article in English | MEDLINE | ID: mdl-31857242

ABSTRACT

Numerous agents (approximately 90) are shown to stimulate hair growth in cellular and animal models in a hormetic-like biphasic dose response manner. These hormetic dose responses occur within the framework of direct stimulatory responses as well as in preconditioning experimental protocols. These findings have important implications for experimental and clinical investigations with respect to study design strategies, dose selection and dose spacing along with sample size and statistical power issues. These findings further reflect the general occurrence of hormetic dose responses within the biological and biomedical literature that consistently appear to be independent of biological model, level of biological organization (i.e., cell, organ, and organism), endpoint, inducing agent, potency of the inducing agent, and mechanism.


Subject(s)
Hair/growth & development , Hormesis , Animals , Hair/drug effects , Humans , Panax , Plant Preparations/therapeutic use
19.
J Cosmet Laser Ther ; 22(1): 1-7, 2020.
Article in English | MEDLINE | ID: mdl-29028377

ABSTRACT

Background: In treating androgenetic alopecia, 5% minoxidil is a commonly used topical drug. By using electrodynamic microneedle at the same time may increase absorption of minoxidil and further stimulate hair growth.Objective: A 24-week, randomized, evaluator blinded, comparative study was performed to evaluate the efficacy of treating Chinese male androgenetic alopecia using microneedle combined with 5% minoxidil topical solution. Methods: Randomized subjects received topical 5% minoxidil (group 1, n = 20), local electrodynamic microneedle treatments (group 2, n = 20), or local electrodynamic microneedle treatments plus topical 5% minoxidil (group 3, n = 20). A total of 12 microneedle treatments were performed every 2 weeks with 2ml 5% minoxidil delivery in group three during each microneedle treatment. Patient receiving topical 5% minoxidil applied 1 ml of the solution twice daily over the course of the study. A total of 60 Chinese male subjects with Norwood-Hamilton type III-VI androgenetic alopecia were treated.Results: The mean improvement in total hair density from baseline to 24 weeks was 18.8/cm2 in group 1, 23.4/cm2 in group 2, and 38.3/cm2 in group 3. The hair growth in the three groups was significantly different (P = 0.002), but there were no significant differences in toxicity found between the three groups.Conclusions: Treatment with microneedle plus topical 5% minoxidil was associated with the best hair growth.


Subject(s)
Alopecia/drug therapy , Electric Stimulation Therapy/methods , Hair/growth & development , Minoxidil/administration & dosage , Needles , Adult , Double-Blind Method , Hair/drug effects , Humans , Injections, Intradermal/methods , Male , Middle Aged , Treatment Outcome
20.
Nat Prod Res ; 34(12): 1750-1755, 2020 Jun.
Article in English | MEDLINE | ID: mdl-30513209

ABSTRACT

An aliphatic ester of hydroxysalicylic acid (6), reported for the first time from a natural source in addition to five known compounds were isolated from the fermented Carica papaya L. preparation, a commercialized functional food. The known compounds were identified as 5-hydroxymethylfurfuraldehyde (1), trans-caffeic acid (2), butyl 4-hydroxybenzoate (butylparaben) (3), lycopene (4), benzyl isothiocyanate (5). Compounds 1 and 3 were reported for the first time from Papaya fruits through this study. The new compound showed a moderate antioxidant activity and a potent hair growth stimulating activity in vitro.


Subject(s)
Antioxidants/isolation & purification , Carica/chemistry , Hair/growth & development , Plant Preparations/chemistry , Salicylic Acid/chemistry , Antioxidants/pharmacology , Esters , Fruit/chemistry , Hair/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Salicylic Acid/isolation & purification , Salicylic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL